Compliance Rate

Compliance Rate 48.0%
Compliant submissions 48
Incompliant submissions 52
Total trials 100

Your Clinical Trials

Showing 538475 of 542236 entries
View as:

Efficacy of a Minimally Invasive Therapy Adjuvant to the Standards of Care by Cyanoacrylate Embolization

Phase: N/A Priority: Normal
NCT ID: NCT05374681 Org: User:
Start: 03/28/23 End: 09/28/26 Due: 09/28/27

Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients

Phase: N/A Priority: Normal
NCT ID: NCT06447480 Org: User:
Start: 07/01/25 End: 09/01/27 Due: 09/01/28

Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04533958 Org: User:
Start: 09/28/20 End: 02/28/27 Due: 02/28/28

Efficacy of a Multimodal Brain Health Intervention for Older African Americans

Phase: N/A Priority: Normal
NCT ID: NCT04863378 Org: User:
Start: 02/01/22 End: 10/01/23 Due: 10/01/24

The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure

Phase: N/A Priority: Normal
NCT ID: NCT03375892 Org: User:
Start: 03/03/18 End: 03/21/21 Due: 03/21/22

A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06364696 Org: User:
Start: 04/16/24 End: 04/30/27 Due: 04/30/28

A Study of PCSK9 Inhibitor AK102 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04169386 Org: User:
Start: 05/23/18 End: 11/22/18 Due: 11/22/19

Using Virtual Reality Before Transcranial Magnetic Stimulation for the Treatment of OCD

Phase: N/A Priority: Normal
NCT ID: NCT06442527 Org: User:
Start: 05/31/25 End: 12/31/25 Due: 12/31/26

Chronic GVHD Response Measures Validation

Phase: N/A Priority: Normal
NCT ID: NCT01902576 Org: User:
Start: 06/30/13 End: 02/28/27 Due: 02/28/28

Gastric Ultrasound in Pediatric Trauma Patients

Phase: N/A Priority: Normal
NCT ID: NCT05330351 Org: User:
Start: 03/26/22 End: 12/31/26 Due: 12/31/27

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

Phase: N/A Priority: Normal
NCT ID: NCT04641247 Org: User:
Start: 04/16/21 End: 11/13/25 Due: 11/13/26

Videos for Advance Care Planning in Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT04149704 Org: User:
Start: 12/13/19 End: 05/05/22 Due: 05/05/23

The Substance Use and Health Risk Intervention (SUHRI) for Justice-involved Youth

Phase: N/A Priority: Normal
NCT ID: NCT06132282 Org: User:
Start: 06/21/22 End: 07/27/23 Due: 07/27/24

Microvention AnEurysm & STroke Real-life Data cOllection

Phase: N/A Priority: Normal
NCT ID: NCT06494436 Org: User:
Start: 12/30/24 End: 06/30/30 Due: 06/30/31

Cyclosporine a Pretreatment and Kidney Graft Function

Phase: N/A Priority: Normal
NCT ID: NCT02907554 Org: User:
Start: 12/19/17 End: 04/03/23 Due: 04/03/24

An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04871139 Org: User:
Start: 04/08/21 End: 03/01/26 Due: 03/01/27

An Open-Label, Phase 2 Trial of Nanatinostat in Combination With Valganciclovir in Patients With Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT05011058 Org: User:
Start: 05/28/21 End: 01/31/25 Due: 01/31/26

Intelligent Hypertension Intervention Study

Phase: N/A Priority: Normal
NCT ID: NCT05526300 Org: User:
Start: 09/06/22 End: 12/01/24 Due: 12/01/25

Effect of (TaVNS) on Anxiety and Brain Function in Distressed Health Care Workers

Phase: N/A Priority: Normal
NCT ID: NCT05132881 Org: User:
Start: 04/01/21 End: 04/01/25 Due: 04/01/26

Simulation-informed Modelling and Personalized Evaluation (SIMPLE) in Ageing Populations

Phase: N/A Priority: Normal
NCT ID: NCT06572332 Org: User:
Start: 01/01/25 End: 12/31/26 Due: 12/31/27

A Study of LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03936959 Org: User:
Start: 05/24/19 End: 04/29/21 Due: 04/29/22

Auricular Acupuncture as Part of Multimodal Analgesia After Lower Leg Fracture

Phase: N/A Priority: Normal
NCT ID: NCT05984433 Org: User:
Start: 10/09/24 End: 12/31/26 Due: 12/31/27

Photobiomodulation and Parkinson

Phase: N/A Priority: Normal
NCT ID: NCT03811613 Org: User:
Start: 01/29/18 End: 03/30/18 Due: 03/30/19

Prospective Observational Trial of IAPA

Phase: N/A Priority: Normal
NCT ID: NCT04530799 Org: User:
Start: 03/10/22 End: 06/30/26 Due: 06/30/27

Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04920656 Org: User:
Start: 04/01/21 End: 02/01/25 Due: 02/01/26